Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics
Aims: Patients with familial hypercholesterolemia (FH) are known to have higher exposure to coronary risk than those without FH with similar low-density lipoprotein cholesterol (LDL-C) level. Lipid-lowering medications (LLMs) are the mainstay treatments to lower the risk of premature coronary artery...
Published in: | Journal of Atherosclerosis and Thrombosis |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Japan Atherosclerosis Society
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85162056339&doi=10.5551%2fJAT.63389&partnerID=40&md5=833730496bf6a586e927124e395ae527 |